PLAA Antikörper (AA 101-200)

Produktnummer ABIN704411

Produktdetails anti-PLAA Antikörper

Target: PLAA (Phospholipase A2-Activating Protein (PLAA))

Bindungsspezifität: AA 101-200

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PLAA Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Homologie: Human,Mouse,Rat,Dog,Cow,Pig,Horse,Rabbit

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human Phospholipase A2 activator protein

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit: 12 months

Referenzen für anti-PLAA Antikörper (ABIN704411)

Rosing, Fobker, Kannenberg, Gunia, DellAquila, Kwiecien, Stypmann, Nofer: "Everolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients." in: Atherosclerosis, Vol. 230, Issue 1, pp. 164-70, (2013) (PubMed).

Details zu PLAA

Target: PLAA (Phospholipase A2-Activating Protein (PLAA))

Andere Bezeichnung: PLAA/Phospholipase A2 activator protein (PLAA Produkte)

Synonyme: cb623 antikoerper, zgc:56568 antikoerper, zgc:66193 antikoerper, wu:fc45d08 antikoerper, wu:fi33e06 antikoerper, PLAA antikoerper, doa1 antikoerper, pla2p antikoerper, plap antikoerper, DOA1 antikoerper, PLA2P antikoerper, PLAP antikoerper, 2410007N06 antikoerper, AI536418 antikoerper, AU018445 antikoerper, AW208417 antikoerper, D4Ertd618e antikoerper, Ufd3 antikoerper, Plap antikoerper, phospholipase A2-activating protein antikoerper, phospholipase A2 activating protein antikoerper, phospholipase A2-activating protein L homeolog antikoerper, phospholipase A2-activating protein S homeolog antikoerper, phospholipase A2, activating protein antikoerper, plaa antikoerper, PLAA antikoerper, plaa.L antikoerper, plaa.S antikoerper, Plaa antikoerper

Hintergrund:

Synonyms: DOA1, PLAP, PLA2P, Phospholipase A-2-activating protein, PLAA

Background: Phospholipase A2 activator protein (PLAP), activates PLA2 (phospholipase A2 enzyme) and is an important mediator of eicosanoid generation. Also known as a pro-inflammatory agent, PLAP has been found in inflamed tissues and synovial fluid from patients with rheumatoid arthritis. As such, it is believed to play an important role in the regulation of inflammatory diseases. The formation of PLAP can be stimulated by IL-1 beta and TNF-alpha.

Gen-ID: 9373

UniProt: Q9Y263